MOMA's research program is anchored at the Institute for Clinical Medicine, Aarhus University and Aarhus University Hospital.
The project lists contain larger projects and network and are not complete. Please, follow the links for further details about projects and network.
Effects of Germline Structural Variation on the Biology and Pathology of the Large Intestine (2021-2024)
CIRCPAC – A National Randomized Trial Investigating the Clinical Benefit of circulating tumor DNA Guided Recurrence Surveillance After Resection for Pancreatic Cancer (2020-)
UTILITY - Using liquid tumor biopsies & genetic testing to guide personalized treatment of advanced prostate cancer: From discovery to clinical care. (2020-)
TOMBOLA - Treatment of Metastatic Bladder cancer at the time of biochemical reLApse following radicial cystectomy (2020-)
DCCC ctDNA Research Center - Danish National Center for Circulating Tumor DNA Guided cancer Treatment (2020-)
DCCC Danish circulating tumor DNA network (DCCC ctDNA) (2019-)
NorDCaP - Nordic Implementation of Personalised Prostate Cancer Diagnostics (2019-)
PRIMA - Early and accurate detection of prostate cancer in general practice (2018-)
IMPROVE - Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer (2018-2025)
IMPROVE-IT - Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer (2018-2025)
IMPROVE-IT2 - Implementing noninvasive circulating tumor DNA analysis to optimize the operative and postoperative treatment for patients with colorectal cancer – intervention trial 2 (2018-2025)
"Individualized monitoring of cancer by deep sequencing of circulating tumor DNA in patients with advanced bladder cancer "(2017-)
PROCARIS - A new strategy to prevent overdiagnosis and overtreatment of non-aggressive prostate cancer in the aging male population (2016-)
PAGER - Analyzis of personal genomic rearrangements for surveillance of patients with bladder cancer (2013-)
OPRA - Oncology Precision Medicine Project Aarhus (2017-)
NEXT - Danish study of personalised cancer therapy based on tumor genetics (2017-)
""Early detection of recurrence and more curative therapy for colon cancer patients" (2016-2020)
PanCancer Analysis of Whole Genomes (PCAWG) Project (2015-)
NoNEDG - Nordic Centre of Excellence Programme in Molecular Medicine (2005-2010)
The MicroRNA Research Consortium – Towards novel molecular targets for LNA-based cancer therapy (2006-2008)
NOCRC "Novel Colorectal Cancer Screening Tools Improve Survival and Cost-effectiveness" (2014-2019)
Improved Molecular Diagnostics for Prostate Cancer, The Danish National Advanved Technology Foundation (2013-2017)
SYSCOL - EU FP7 project "Systems Biology of Colorectal Cancer" (2011-2015)
MOLPROS - "Molecular Prediction of Prostate Cancer Risk and Aggressiveness" (MPRAS), The Danish Council for Strategic Research (2011-2014)
Uromol - EU FP7 project "Prediction of bladder cancer disease course using risk scores that combine molecular and clinical risk factors" (2008-2013)
CETAME - The Lundbeck Foundation Center for Translational Medicine (2008-2013)
CMCC - Center for Molecular Clinical Cancer Research, A John and Birthe Meyer Cancer Center (2005-2014)
"Improved Molecular Diagnostics for Prostate Cancer" (2013-2017), Innovation Fund Denmark
"Precision medicine for clinically localised prostate cancer" (2014-2017), Danish Cancer Society, Knæk Cancer bevilling 2012
"Genetic stratification for prostate cancer risk and aggressiveness evaluated by a clinical intervention study" (2015-2017), Danish Cancer Society, Knæk Cancer bevilling 2014
"Precision medicine for colon cancer using the genetic profile of the patient" (2015-2017), Danish Cancer Society, Knæk Cancer bevilling 2014
"More precise diagnosis for men with prostate cancer", (2015-2018), Danish Cancer Society, Knæk Cancer bevilling 2013
Long non-coding RNAs as biomarkers and novel drivers of human bladder cancer (2014-2017)
